Profile

Michael David Gautreaux, Ph.D.Wake Forest School of Medicine

Michael David Gautreaux, Ph.D.

Professor,

Contact Information

Academic: 336-716-4456 | Department: 336-716-5492

Email: mgautrea@wakehealth.edu

Education & Training

  • B.S., Louisiana State University & A&M College , 1987
  • Ph.D., LSU School of Medicine-Shreveport , 1994
  • Fellowship, Immunology, LSU School of Medicine-Shrevep, 1998

NPI Number

  • 1427129279
Michael David Gautreaux, Ph.D.

Michael David Gautreaux, Ph.D.

Professor, Pathology

Contact Information

Academic: 336-716-4456 | Department: 336-716-5492

Email: mgautrea@wakehealth.edu

Recent Publications

Al-Shraideh Y, Stratta R, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Bodner J, Uloko V, Winfrey S, Kaczmorski S, Doares W, Mangus M, Gautreaux M, Iskandar S, Rogers J. Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Transplantation. 2014;98(Suppl 1):631.

Farney A, Rogers J, Doares W, Iskandar S, Orlando G, Adams P, Gautreaux M, Kaczmorski S, Stratta R. 7 year results of a prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in kidney and kidney pancreas transplantation [abstract]. Transplantation. 2014;98(Suppl 1):90.

Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Doares W, Kaczmorski S, Stratta R. Similar results with solitary pancreas transplantation compared to simultaneous pancreas-kidney transplantation in the new millennium [abstract]. Transplantation. 2014;98(Suppl 1):854.

Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Winfrey S, Uloko V, Bodner J, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Freedman B, Stratta R. Does donor ethnicity influence kidney transplant outcome after simultaneous kidney-pancreas transplantation? [abstract]. Transplantation. 2014;98(Suppl 1):861.

Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Rogers J. Expanded criteria donors: the end of an era [abstract]. Transplantation. 2014;98(Suppl 1):654.

Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Rogers J. Experience with deceased donor kidney transplantation in 114 septuagenarians [abstract]. Transplantation. 2014;98(Suppl 1):600.

Stratta R, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Farney A. Dual kidney transplants from adult marginal donors: double or nothing [abstract]. Transplantation. 2014;98(Suppl 1):595-596.

Al-Shraideh Y, Farooq U, Farney AC, Palanisamy A, Rogers J, Orlando G, Buckley MR, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ. Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era. Clin Transplant. 2014;():.

Askar M, Daghstani J, Thomas D, Leahy N, Dunn P, Claas F, Doran S, Saji H, Kanangat S, Karoichane M, Tambur A, Monos D, El-Khalifa M, Turner V, Kamoun M, Mustafa M, Ramon D, Gandhi M, Vernaza A, Gorodezky C,. 16th IHIW: global distribution of extended HLA haplotypes. Int J Immunogenet. 2013;40(1):31-38.

Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Gautreaux M, Winfrey S, Uloko V, Iskandar S, Brim E, Hairston G, Stratta R. Transplantation of CDC high risk kidneys: a low risk option for a high risk problem [abstract]. Am J Transplant. 2013;13(Suppl 5):403.

Boldt B, Burton M, McDougan F, Kimball P, Stewart JW, Brown SB, Gautreaux M. Increased antibody detection with expanded panel of antigens in lifecodes class II IDV2 (LM2Q) [abstract]. Hum Immunol. 2013;74(5):491.


Rogers J, Farney A, Iskandar S, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Gautreaux M, Stratta RJ. Similar results with solitary pancreas compared to simultaneous kidney-pancreas transplantation in the new millennium [abstract]. Transplantation. 2013;96(6 Suppl):S11.

Farney A, Rogers J, Hart L, Doares W, Iskandar S, Orlando G, Adams P, Gautreaux M, Kaczmorski S, Stratta R. Long-term results of a prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in kidney and kidney pancreas transplantation [abstract]. Am J Transplant. 2012;12(Suppl 3):56.

McArthur MC, Iskandar S, Farney A, Gautreaux M, Doares W, Kaczmorski S, Ghanta M, Reeves-Daniel A, Orlando G, Stratta RJ, Rogers J. Does alemtuzumab induction and negative flow cytometry crossmatching abrogate the need for early graft biopsies in the setting of delayed graft function? [abstract]. Am J Transplant. 2012;12(Suppl 3):372.

Rogers J, Farney A, Orlando G, Brim E, Hairston G, Reeves-Daniel A, Ghanta M, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Winfrey S, McArthur MC, Uloko V, Stratta R. Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Am J Transplant. 2012;12(Suppl 3):246-247.

Winfrey SA, Al-Geizawi S, Farney A, Gautreaux M, Doares W, Kaczmorski S, Ghanta M, Reeves-Daniel A, Orlando G, Stratta RJ, Rogers J. Influence of donor and recipient ethnicity on outcomes following deceased donor kidney transplantation [abstract]. Am J Transplant. 2012;12(Suppl 3):524.

Brown SB, Kiger DF, Rogers J, Gautreaux MD. DP or not DP? That is the question [abstract]. Hum Immunol. 2012;73(Suppl 1):62.

O'Shields EF, Kiger DF, Gautreaux MD. Time ain't on our side: real-time PCR for deceased donor typings [abstract]. Hum Immunol. 2012;73(Suppl 1):142.

Stewart JW, O'Shields EF, Kiger DF, Gautreaux MD. Back to the future: heat-treating for solid phase antibody testing [abstract]. Hum Immunol. 2012;73(Suppl 1):62.

Algeizawi S, Farney A, Rogers J, Reeves-Daniel A, Doares W, Winfrey S, Kaczmorski S, Gautreaux M, Iskandar S, Adams P, Stratta R. Experience with deceased donor kidney transplantation in patients over age 70: is rationing justified? [abstract]. Am J Transplant. 2011;11(Suppl 1):74.

Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin J-J, Kiger DF, Gautreaux MD, Divers J, Freedman BI. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011;11(5):1025-1030.

Algeizawi S, Farney A, Rogers J, Gautreaux M, Doares W, Kaczmorski S, Winfrey S, Ghanta M, Reeves-Daniel A, Adams P, Stratta R. Effect of high donor BMI on short term outcomes in expanded criteria deceased donor kidney transplants (DDKT) [abstract]. Am J Transplant. 2011;11(Suppl 2):228.

Kaczmorski S, Doares W, Al-Geizawi S, Gautreaux M, Reeves-Daniel A, Adams P, Ghanta M, Rogers J, Farney A, Stratta R. Are HIV-positive patients at higher risk for BK viral infection following kidney transplantation? [abstract]. Am J Transplant. 2011;11(Suppl 2):259.

Gautreaux MD, Kiger DF, Winfrey SC, Farney AF [sic] [Farney AC], Rogers J, Beane KN, Victor B, Stewart JW, Stratta RJ. Incorporating a urinary biomarker assay into clinical laboratory practice [abstract]. Am J Transplant. 2011;11(Suppl 2):270.

Rogers J, Farney A, Al-Geizawi S, Doares W, Kaczmorski S, Winfrey S, Gautreaux M, Hart L, Iskandar S, Adams P, Hairston G, Stratta R. Simultaneous kidney-pancreas transplantation in African-American recipients: alemtuzumab versus rATG induction [abstract]. Am J Transplant. 2011;11(Suppl 2):436.

Doares W, Kaczmorski S, Williamson J, Al-Geizawi S, Gautreux M [sic] [Gautreaux M], Reeves-Daniel A, Adams P, Rogers J, Farney A, Stratta R. Millions of dollars baby: is use of IVIG to prevent rejection in sensitized renal and pancreas transplant recipients effective? [abstract]. Am J Transplant. 2011;11(Suppl 2):450-451.

Rogers J, Iskandar S, Farney A, Al-Geizawi S, Reeves-Daniel A, Ghanta M, Doares W, Kaczmorski S, Gautreaux M, Adams P, Stratta R. Long-term outcomes of solitary pancreas transplantation: do surveillance pancreas biopsies level the playing field? [abstract]. Am J Transplant. 2011;11(Suppl 2):431.

Al-Geizawi S, Farney A, Rogers J, Reeves-Daniel A, Ghanta M, Winfrey S, Gautreaux M, Doares W, Kaczmorski S, Adams P, Stratta R, et al. 70 deceased donor kidney transplants in patients over age 70: is 70 the new 50? [abstract]. Am J Transplant. 2011;11(Suppl 2):241.

Rogers J, Farney AC, Al-Geizawi S, Iskandar SS, Doares W, Gautreaux MD, Hart L, Kaczmorski S, Reeves-Daniel A, Winfrey S, Ghanta M, Adams PL, Stratta RJ. Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center. Rev Diabet Stud. 2011;8(1):17-27.

Singh RP, Farney AC, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Doares W, Iskandar S, Adams P, Stratta RJ. Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation. Clin Transplant. 2011;25(4):E437-E446.

Beane KN, Stewart JW, Kiger DF, Rogers J, Gautreaux MD. A urinary biomarker assay in clinical practice [abstract]. Hum Immunol. 2011;72(Suppl 1):S67.

Brown SB, Kiger DF, O'Shields EF, Gautreaux MD. Eliminating the red menace [abstract]. Hum Immunol. 2011;72(Suppl 1):S161.

O'Shields EF, Kiger DF, Petty CC, Franz J, Gautreaux MD. Comparison of DNA quantity and quality from different deceased donor sources isolated by an automatic system [abstract]. Hum Immunol. 2011;72(Suppl 1):S163.

Gautreaux MD, Kiger DF, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Al-Gezawi SM, Stratta RJ. Gauging the guess: comparing virtual crossmatching to the real thing [abstract]. Am J Transplant. 2010;10(Suppl 4):190.

Farney AC, Rogers J, Al-Geizawi S, Reeves-Daniel A, Hartmann E, Adams P, Gautreaux M, Winfrey S, Iskandar S, Stratta R, et al. Infection or rejection: chicken or egg? [abstract]. Am J Transplant. 2010;10(Suppl 4):320.

Al-Geizawi S, Hartmann E, Farney A, Rogers J, Reeves-Daniel A, Winfrey S, Gautreaux M, Iskandar S, Adams P, Stratta R, et al. Experience with deceased donor kidney transplantation in patients over age 70: better late than never! [abstract]. Am J Transplant. 2010;10(Suppl 4):335-336.

Rogers J, Farney A, Iskandar S, Reeves-Daniel A, Hartmann E, Al-Geizawi S, Winfrey S, Gautreaux M, Adams P, Stratta R, et al. Baseline biopsies of live donor renal allografts: 'you can observe a lot just by watching' [abstract]. Am J Transplant. 2010;10(Suppl 4):535.

Stratta RJ, Al-Geizawi S, Hartmann EL, Farney AC, Rogers J, Reeves-Daniel A, Doares W, Winfrey S, Kaczmorski S, Gautreaux M, Iskandar S, Adams PL. Experience with deceased donor kidney transplantation in patients over age 70: better late than never [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():P39.58.

Gautreaux MD, Kiger DF, Farney AC, Rogers J, Singh RP, Hartmann EL, Reeves-Daniel AM, Stratta RJ. The virtual crossmatch in kidney transplantation: is that your final answer? [abstract]. Am J Transplant. 2009;9(Suppl 2):488.

Hartmann EL, Doares W, Reeves-Daniel A, Rogers J, Singh R, Hart L, Gautreaux M, Stratta RJ, Farney A. Safety and efficacy of lymphocyte-depleting induction therapy in older transplant recipients: should grandpa receive Campath? [abstract]. Am J Transplant. 2009;9(Suppl 2):675.

Rogers J, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Singh R, Doares W, Gautreaux M, Adams P, Stratta R. Rejection on early surveillance biopsies after renal transplantation: finding snakes in the grass [abstract]. Am J Transplant. 2009;9(Suppl 2):513.

Rogers J, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Singh R, Doares W, Gautreaux M, Adams P, Stratta R. What can reperfusion and 1 month surveillance biopsies tell us about early renal allograft function? [abstract]. Am J Transplant. 2009;9(Suppl 2):588.

Singh R, Farney A, Rogers J, Doares W, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. A randomized, prospective trial of alemtuzumab versus rabbit anti-thymocyte globulin induction in kidney-pancreas transplantation: a single center experience [abstract]. Am J Transplant. 2009;9(Suppl 2):216.

Singh R, Farney A, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta R. Donor hypertension is the most important pretransplant factor predicting graft loss in kidney transplantation from donation after brain death standard criteria donors [abstract]. Am J Transplant. 2009;9(Suppl 2):222-223.

Singh R, Hines M, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Kiger D, Iskandar S, Adams P, Stratta R. A single center experience using extracorporeal support in donation after cardiac death donors: improved outcomes for renal and extrarenal transplantation [abstract]. Am J Transplant. 2009;9(Suppl 2):234-235.

Singh R, Farney A, Iskandar S, Rogers J, Gautreaux M, Hartmann E, Reeves-Daniel A, Adams P, Stratta R. Banff '97 type 2a rejection: the extent of tubulointerstitial inflammation matters [abstract]. Am J Transplant. 2009;9(Suppl 2):509.

Singh R, Farney A, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta R. Recipient factors affecting outcomes in deceased donor kidney transplantation [abstract]. Am J Transplant. 2009;9(Suppl 2):516.

Singh R, Zuckerman J, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R, et al. A seven year experience with 222 expanded criteria donor kidney transplants at a single center [abstract]. Am J Transplant. 2009;9(Suppl 2):567.

Singh R, Farney A, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta R. Native end stage renal disease due to immune causes adversely influences outcomes in kidney transplantation from donation after brain death standard criteria donors [abstract]. Am J Transplant. 2009;9(Suppl 2):683-684.

Farney AC, Rogers J, Singh R, Hartmann E, Hart L, Reeves-Daniel A, Gautreaux M, Iskandar SS, Adams PL, Stratta RJ, et al. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation. 2009;88(6):810-819.

Freedman BI, Nagaraj SK, Lin JJ, Gautreaux MD, Bowden DW, Iskandar SS, Stratta RJ, Rogers J, Hartmann EL, Farney AC, Reeves-Daniel AM. Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation. Am J Transplant. 2009;9(10):2435-2440.

Stratta R, Singh R, Farney A, Rogers J, Doares W, Hartman E [sic] [Hartmann E], Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P. A randomized, prospective trial of alemtuzumab versus rabbit anti-thymocyte globulin induction in kidney-pancreas transplantation: a single center experience [abstract]. Transpl Int. 2009;22(Suppl 2):76-77.

Stratta R, Singh R, Hines M, Farney A, Rogers J, Hartman E [sic] [Hartmann E], Reeves-Daniel A, Gautreaux M, Kiger D, Iskandar S, Adams P. A single center experience using extracorporeal support in donation after cardiac death donors [abstract]. Transpl Int. 2009;22(Suppl 2):102.

Stratta R, Singh R, Zuckerman J, Farney A, Rogers J, Hartman E [sic] [Hartmann E], Reeves-Daniel A, Gautreaux M, Iskandar S, Hairston G, Adams P. A seven year experience with 222 expanded criteria donor kidney transplants at a single center [abstract]. Transpl Int. 2009;22(Suppl 2):191.

Gautreaux M, Kiger D, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Stratta R. The virtual crossmatch in kidney transplantation: psychic or psychotic? [abstract]. Hum Immunol. 2009;70(Suppl 1):S20.

Singh RP, Rogers J, Farney AC, Moore PS, Hartmann EL, Reeves-Daniel A, Adams PL, Gautreaux M, Stratta RJ. Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage. Transplant Proc. 2008;40(2):502-505.

Farney AC, Singh RP, Hines MH, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL, Stratta RJ. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support. J Am Coll Surg. 2008;206(5):1028-1037.

Gautreaux MD, Rebellato LM, Kiger DF, Haisch CE, Stratta RJ. Cytokine gene polymorphisms in caucasian and African American renal allograft recipients--a multi-year follow-up [abstract]. Am J Transplant. 2008;8(Suppl 2):350.

Rogers J, Pomper G, Singh R, Farney A, Hartmann E, Reeves-Daniel A, Iskandar S, Gautreaux M, Adams P, Stratta R, et al. Blood transfusion after renal transplantation is associated with inferior early outcome [abstract]. Am J Transplant. 2008;8(Suppl 2):369.

Singh RP, Farney A, Rogers J, Zuckerman JM, Gautreaux M, Iskandar S, Adams P, Stratta R. Impact of native end stage renal disease on kidney allograft outcomes: rejection or infection? A multivariate analysis [abstract]. Am J Transplant. 2008;8(Suppl 2):351.

Singh RP, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL, Stratta RJ. Expanded versus standard criteria donors in kidney transplantation: does donor and recipient age-matching make a difference? [abstract]. Am J Transplant. 2008;8(Suppl 2):368-369.

Singh RP, Zuckerman JM, Farney A, Rogers J, Hartmann E, Gautreaux M, Reeves-Daniel A, Iskandar S, Adams P, Stratta R. Lack of impact of delayed graft function on post-transplant outcomes in kidney transplantation from donation after cardiac death donors [abstract]. Am J Transplant. 2008;8(Suppl 2):369.

Singh RP, Gautreaux MD, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Kiger DF, Iskandar SS, Adams PL, Stratta RJ. Should kidneys from zero-antigen mismatch expanded criteria donors be shared? [abstract]. Am J Transplant. 2008;8(Suppl 2):392.

Singh RP, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Zuckerman JM, Iskandar SS, Adams PL, Stratta RJ. Multivariate analysis of risk factors for acute rejection and kidney allograft loss according to recipient age [abstract]. Am J Transplant. 2008;8(Suppl 2):522.

Singh RP, Farney A, Rogers J, Ashcraft E, Doares W, Hartmann E, Reeves-Daniel A, Gautreaux M, Adams P, Stratta R. Experience with alemtuzumab versus rabbit anti-thymocyte globulin induction in pancreas transplantation [abstract]. Am J Transplant. 2008;8(Suppl 2):556.

Singh RP, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Risk factors for graft loss in expanded versus standard criteria kidneys: a multivariate analysis [abstract]. Am J Transplant. 2008;8(Suppl 2):600.

Stratta RJ, Farney AC, Rogers J, Singh RP, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL. Experience with extended donors and recipients in simultaneous kidney-pancreas transplantation [abstract]. Am J Transplant. 2008;8(Suppl 2):200.

Stratta RJ, Singh RP, Farney AC, Rogers J, Hines MH, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL. Single center experience in kidney and kidney-pancreas transplantation with donation after cardiac death donors with selective use of extracorporeal support [abstract]. Am J Transplant. 2008;8(Suppl 2):367.

Ward WG, Gautreaux MD, Lippert DC II, Boles C. HLA sensitization and allograft bone graft incorporation. Clin Orthop Relat Res. 2008;466(8):1837-1848.

Stratta RJ, Moore PS, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL. Influence of pulsatile perfusion preservation on outcomes in kidney transplantation from expanded criteria donors. J Am Coll Surg. 2007;204(5):873-884.

Gautreaux MD, Kiger DF, Robinson DL, Reeves-Daniel AM, Adams PL, Hartmann EL, Farney AC, Rogers J, Stratta RJ. A positive T-cell flow cytometric crossmatch may not be a contraindication to renal transplant [abstract]. Am J Transplant. 2007;7(Suppl 2):289.

Rogers J, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Doares W, Ashcraft E, Gautreaux M, Adams P, Stratta R. Surveillance pancreas biopsies in solitary pancreas transplantation: a shot in the dark? [abstract]. Am J Transplant. 2007;7(Suppl 2):251.

Gautreaux MD, Kiger DF, Robinson DL, Reeves-Daniel AM, Adams PL, Hartmann EL, Farney AC, Rogers J, Stratta RJ. A positive T-Cell flow cytometric crossmatch may not be a contraindication to renal transplant [abstract]. Am J Transplant. 2007;7(Suppl 2):289.

Moore PS, Farney AC, Rohr MS, Hartmann EL, Iskandar SS, Gautreaux MD, Rogers J, Anderson TK, Adams PL, Stratta RJ, et al. Dual kidney transplantation: a case-control comparison with single kidney transplantation from standard and expanded criteria donors. Transplantation. 2007;83(12):1551-1556.

Farney AC, Singh RP, Rogers J, Ashcraft E, Doares W, Hartmann EL, Reeves-Daniel A, Gautreaux M, Adams PL, Stratta RJ. Experience with alemtuzumab versus rabbit anti-thymocyte globulin induction in pancreas transplantation [abstract]. Xenotransplantation. 2007;14(5):382.

Farney AC, Singh RP, Moore PS, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux M, Adams PL, Stratta RJ. Does recipient age influence outcomes in pancreatic transplantation? [abstract]. Xenotransplantation. 2007;14(5):522.

Singh RP, Rogers J, Farney AC, Moore PS, Hartmann EL, Reeves-Daniel A, Adams PL, Gautreaux M, Stratta RJ. Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage [abstract]. Xenotransplantation. 2007;14(5):414.

Moore PS, Farney AC, Hartmann EL, Rogers J, Doares W, Gautreaux MD, Iskandar SS, Hairston G, Adams PL, Stratta RJ. Experience with deceased donor kidney transplantation in 114 patients over age 60. Surgery. 2007;142(4):514-523.

Aurora D, Balazs I, Davies A, Ebner D, Gautreaux M, Jiang N, Ray B, Zaslavskaia L. Application of class II single antigens for defining antibody epitope specificities [abstract]. Hum Immunol. 2007;68(Suppl 1):S13.

Mostecki J, Hariharan J, Ebner D, Ray B, Gautreaux M, Balazs I. HLA class I epitope identification by the use of adsorption and elution of HLA-specific antibodies from sera using single antigens [abstract]. Hum Immunol. 2007;68(Suppl 1):S78.

Singh R, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Evolving criteria for accepting deceased donor kidneys for transplantation [abstract]. Transpl Int. 2007;20(Suppl 2):38.

Singh R, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Expanded versus standard criteria donors in kidney transplantation: does age matching make a difference? [abstract]. Transpl Int. 2007;20(Suppl 2):106.

Singh R, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Multivariate analysis of risk factors for graft loss in expanded versus standard criteria deceased donors in kidney transplantation [abstract]. Transpl Int. 2007;20(Suppl 2):244.

Stratta R, Moore P, Farney A, Rogers J, Hartmann E, Gautreaux M, Adams P. Does recipient age make a difference in pancreas transplantation? [abstract]. Transpl Int. 2007;20(Suppl 2):310.

Moore PS, Farney AC, Sundberg AK, Rohr MS, Hartmann EL, Iskandar SS, Gautreaux MD, Rogers J, Anderson TK, Adams PL, Stratta RJ, et al. Experience with dual kidney transplants from donors at the extremes of age. Surgery. 2006;140(4):597-606.

Kiger DF, Stratta R, Farney A, Rogers J, Hartmann E, Gautreaux MD. Transplantation may increase risk for Guillain-Barre Syndrome through donor-specific HLA expression [abstract]. Hum Immunol. 2006;67(Suppl 1):S153.

Gauteaux [sic] MD [Gautreaux MD], Kiger DF, Dollar-Bates A. Expedited delivery overcomes serum supply-chain logistical problems [abstract]. Hum Immunol. 2006;67(10 Suppl):S80.

Kiger DF, Forrest CE, Porter DL, Rucker TJ, Gautreaux MD. Modification of flow crossmatch technique to eliminate false positive T-cell crossmatches [abstract]. Hum Immunol. 2006;67(10):S82.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Pathology

Michael David Gautreaux, Ph.D.

Michael David Gautreaux, Ph.D.

Professor, Pathology

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.